192 related articles for article (PubMed ID: 31548322)
1. Impact of Interleukin-27p28 on T and B Cell Responses during Toxoplasmosis.
Park J; DeLong JH; Knox JJ; Konradt C; Wojno EDT; Hunter CA
Infect Immun; 2019 Dec; 87(12):. PubMed ID: 31548322
[TBL] [Abstract][Full Text] [Related]
2. IL-21 is required for optimal antibody production and T cell responses during chronic Toxoplasma gondii infection.
Stumhofer JS; Silver JS; Hunter CA
PLoS One; 2013; 8(5):e62889. PubMed ID: 23667536
[TBL] [Abstract][Full Text] [Related]
3. Protective efficacy of Toxoplasma gondii calcium-dependent protein kinase 1 (TgCDPK1) adjuvated with recombinant IL-15 and IL-21 against experimental toxoplasmosis in mice.
Chen J; Li ZY; Huang SY; Petersen E; Song HQ; Zhou DH; Zhu XQ
BMC Infect Dis; 2014 Sep; 14():487. PubMed ID: 25192845
[TBL] [Abstract][Full Text] [Related]
4. Endogenous IL-27 during toxoplasmosis limits early monocyte responses and their inflammatory activation by pathological T cells.
Aldridge DL; Moodley D; Park J; Phan AT; Rausch M; White KF; Ren Y; Golin K; Radaelli E; Kedl R; Holland PM; Hill J; Hunter CA
mBio; 2024 Mar; 15(3):e0008324. PubMed ID: 38376210
[TBL] [Abstract][Full Text] [Related]
5. Toxoplasma gondii-Derived Synthetic Peptides Containing B- and T-Cell Epitopes from GRA2 Protein Are Able to Enhance Mice Survival in a Model of Experimental Toxoplasmosis.
Bastos LM; Macêdo AG; Silva MV; Santiago FM; Ramos EL; Santos FA; Pirovani CP; Goulart LR; Mineo TW; Mineo JR
Front Cell Infect Microbiol; 2016; 6():59. PubMed ID: 27313992
[TBL] [Abstract][Full Text] [Related]
6. IL-17 and IL-22 elicited by a DNA vaccine encoding ROP13 associated with protection against Toxoplasma gondii in BALB/c mice.
Alizadeh P; Ahmadpour E; Daryani A; Kazemi T; Spotin A; Mahami-Oskouei M; Flynn RJ; Azadi Y; Rajabi S; Sandoghchian S
J Cell Physiol; 2019 Jul; 234(7):10782-10788. PubMed ID: 30565688
[TBL] [Abstract][Full Text] [Related]
7. Co-administration of interleukins 7 and 15 with DNA vaccine improves protective immunity against Toxoplasma gondii.
Chen J; Li ZY; Petersen E; Liu WG; Zhu XQ
Exp Parasitol; 2016 Mar; 162():18-23. PubMed ID: 26706605
[TBL] [Abstract][Full Text] [Related]
8. Immune response and protective effect against chronic Toxoplasma gondii infection induced by vaccination with a DNA vaccine encoding profilin.
Gao Q; Zhang NZ; Zhang FK; Wang M; Hu LY; Zhu XQ
BMC Infect Dis; 2018 Mar; 18(1):117. PubMed ID: 29514647
[TBL] [Abstract][Full Text] [Related]
9. IL-10 is not required to prevent immune hyperactivity during memory responses to Toxoplasma gondii.
Wille U; Nishi M; Lieberman L; Wilson EH; Roos DS; Hunter CA
Parasite Immunol; 2004 May; 26(5):229-36. PubMed ID: 15491472
[TBL] [Abstract][Full Text] [Related]
10. Increased IL-27/IL-27R expression in association with the immunopathology of murine ocular toxoplasmosis.
Tong X; Chen S; Zheng H; Huang S; Lu F
Parasitol Res; 2018 Jul; 117(7):2255-2263. PubMed ID: 29779048
[TBL] [Abstract][Full Text] [Related]
11. CCR7-dependent immunity during acute Toxoplasma gondii infection.
Noor S; Habashy AS; Nance JP; Clark RT; Nemati K; Carson MJ; Wilson EH
Infect Immun; 2010 May; 78(5):2257-63. PubMed ID: 20194594
[TBL] [Abstract][Full Text] [Related]
12. A role for IL-27p28 as an antagonist of gp130-mediated signaling.
Stumhofer JS; Tait ED; Quinn WJ; Hosken N; Spudy B; Goenka R; Fielding CA; O'Hara AC; Chen Y; Jones ML; Saris CJ; Rose-John S; Cua DJ; Jones SA; Elloso MM; Grötzinger J; Cancro MP; Levin SD; Hunter CA
Nat Immunol; 2010 Dec; 11(12):1119-26. PubMed ID: 21057510
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Protective Immune Response Induced by a DNA Vaccine Encoding GRA8 against Acute Toxoplasmosis in a Murine Model.
Chu JQ; Huang S; Ye W; Fan XY; Huang R; Ye SC; Yu CY; Wu WY; Zhou Y; Zhou W; Lee YH; Quan JH
Korean J Parasitol; 2018 Aug; 56(4):325-334. PubMed ID: 30196664
[TBL] [Abstract][Full Text] [Related]
14. Immunity in the spleen and blood of mice immunized with irradiated Toxoplasma gondii tachyzoites.
Zorgi NE; Galisteo AJ; Sato MN; do Nascimento N; de Andrade HF
Med Microbiol Immunol; 2016 Aug; 205(4):297-314. PubMed ID: 26732075
[TBL] [Abstract][Full Text] [Related]
15. Limited Impact of the Inhibitory Receptor TIGIT on NK and T Cell Responses during
Aldridge DL; Phan AT; de Waal Malefyt R; Hunter CA
Immunohorizons; 2021 Jun; 5(6):384-394. PubMed ID: 34088852
[TBL] [Abstract][Full Text] [Related]
16. IL-33 promotes innate lymphoid cell-dependent IFN-γ production required for innate immunity to
Clark JT; Christian DA; Gullicksrud JA; Perry JA; Park J; Jacquet M; Tarrant JC; Radaelli E; Silver J; Hunter CA
Elife; 2021 Apr; 10():. PubMed ID: 33929319
[TBL] [Abstract][Full Text] [Related]
17. A Toxoplasma gondii vaccine encoding multistage antigens in conjunction with ubiquitin confers protective immunity to BALB/c mice against parasite infection.
Yin H; Zhao L; Wang T; Zhou H; He S; Cong H
Parasit Vectors; 2015 Sep; 8():498. PubMed ID: 26420606
[TBL] [Abstract][Full Text] [Related]
18. [Rudolf-Virchow Prize 1998. Award lecture. Toxoplasmosis: a model infection for studying systemic and intracerebral immune reactions].
Deckert-Schlüter M
Verh Dtsch Ges Pathol; 1998; 82():9-22. PubMed ID: 10095413
[TBL] [Abstract][Full Text] [Related]
19. Recombinant
Czarnewski P; Araújo ECB; Oliveira MC; Mineo TWP; Silva NM
Front Cell Infect Microbiol; 2017; 7():142. PubMed ID: 28487847
[No Abstract] [Full Text] [Related]
20. Impaired innate immunity in mice deficient in interleukin-1 receptor-associated kinase 4 leads to defective type 1 T cell responses, B cell expansion, and enhanced susceptibility to infection with Toxoplasma gondii.
Béla SR; Dutra MS; Mui E; Montpetit A; Oliveira FS; Oliveira SC; Arantes RM; Antonelli LR; McLeod R; Gazzinelli RT
Infect Immun; 2012 Dec; 80(12):4298-308. PubMed ID: 23027530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
